Arthur Kuan is Chairman and Chief Executive Officer of CG Oncology, Inc. (CGON). The company reported total compensation of $11,928,401 for fiscal year 2025.
| Salary | $690,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $3,451,884 |
| Option awards | $7,350,515 |
| Non-equity incentive plan | $414,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $22,002 |
| Total | $11,928,401 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure CG Oncology, Inc. filed April 24, 2026, accession 0001193125-26-177395.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Arthur Kuan this page | Chairman and Chief Executive Officer | $11,928,401 |
| Ambaw Bellete | President and Chief Operating Officer | $4,815,391 |
| Vijay Kasturi | Chief Medical Officer | $3,599,947 |
| Joshua Patterson | General Counsel, Chief Compliance Officer, and Secretary | $2,364,380 |
| Corleen Roche | Prior Chief Financial Officer | $2,322,299 |
| Robert Lapetina | Prior Interim Principal Financial and Accounting Officer | $645,297 |
| Jim DeTore | Chief Financial Officer | $96,000 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full CG Oncology, Inc. compensation brief.
Arthur Kuan's compensation sits inside CG Oncology, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.